Pharmacology of AMPA/kainate receptors

Glutamate and GABA Receptors and Transporters: Structure, Function and Pharmacology

Volumn , Issue , 2001, Pages 99-118

  Madsen, Ulf ^a   Johansen, Tommy N ^a   Stensbøl, Tine B ^a   Krogsgaard Larsen, Povl ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84883992169     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (96)

1. Arai, A., Kessler, M., Xiao, P., Ambros-Ingerson, J., Rogers, G. and Lynch, G.A. (1994) ‘A centrally active drug that modulates AMPA receptor gated currents’, Brain Res. 638: 343-346.
2. Armstrong, N., Sun, Y., Chen, G.-Q. and Gouaux, E. (1998) ‘Structure of a glutamate-receptor ligand-binding core in complex with kainate’, Nature 395: 913-917.
3. Arnt, J., Sánchez, C., Lenz, S.M., Madsen, U. and Krogsgaard-Larsen, P. (1995) ‘Differentiation of in vivo effects of AMPA and NMDA receptor ligands using drug discrimination methods and convulsant/anticonvulsant activity’, Eur. J. Pharmacol. 285: 289-297.
4. Bang-Andersen, B., Lenz, S.M., Skjærbæk, N., Søby, K.K., Hansen, H.O., Ebert, B., Bøgesø, K.P. and Krogsgaard-Larsen, P. (1997) ‘Heteroaryl analogues of AMPA. Synthesis and quantitative structure-activity relationships’, J. Med. Chem. 40: 2831-2842.
5. Banke, T.G. and Lambert, J.D.C. (1999) ‘Novel potent AMPA analogues differentially affect desensitisation of AMPA receptors in cultured hippocampal neurons’, Eur. J. Pharmacol. 367: 405-412.
6. Bischoff, F., Johansen, T.N., Ebert, B., Krogsgaard-Larsen, P. and Madsen, U. (1995) ‘Excitatory amino acid receptor ligands: asymmetric synthesis, absolute stereochemistry and pharmacology of (R)- and (S)-homoibotenic acid’, Bioorg. Med. Chem. 3: 553-558.
7. Bleakman, D., Schoepp, D.D., Ballyk, B., Bufton, H., Sharpe, E.F., Thomas, K., Ornstein, P.L. and Kamboj, R.K. (1996) ‘Pharmacological discrimination of GluR5 and GluR6 kainate receptor subtypes by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinoline-3-carboxylic acid’, Mol. Pharmacol. 49: 581-585.
8. Bowie, D. and Smart, T.G. (1993) ‘Thiocyanate ions selectively antagonize AMPA-evoked responses in Xenopus laevis oocytes microinjected with rat brain mRNA’, Br. J. Pharmacol. 109: 779-787.
9. Bräuner-Osborne, H., Sløk, F.A., Skjærbæk, N., Ebert, B., Sekiyama, N., Nakanishi, S. and Krogsgaard-Larsen, P. (1996) ‘A new highly selective metabotropic excitatory amino acid agonist: 2-amino-4-(3-hydroxy-5-methyl-4-yl)butyric acid’, J. Med. Chem. 39: 3188-3194.
10. Bräuner-Osborne, H., Nielsen, B., Stensbøl, T.B., Johansen, T.N., Skjærbæk, N. and Krogsgaard-Larsen, P. (1997) ‘Molecular pharmacology of 4-substituted glutamic acid analogues at ionotropic and metabotropic excitatory amino acid receptors’, Eur. J. Pharmacol. 335: R1-3.
11. Bräuner-Osborne, H., Nielsen, B. and Krogsgaard-Larsen, P. (1998) ‘Molecular pharmacology of homologues of ibotenic acid at cloned metabotropic glutamic acid receptors’, Eur. J. Pharmacol. 350: 311-316.
12. Chimirri, A., DeSarro, G., DeSarro, A., Gitto, R., Quartarone, S., Zappala, M., Constanti, A. and Libri, V. (1998) '3,5-Dihydro-4H-2,3-benzodiazepine-4-thiones: a new class of AMPA receptor antagonists’, J. Med. Chem. 41: 3409-3416.
13. Christensen, I.T., Reinhardt, A., Nielsen, B., Ebert, B., Madsen, U., Nielsen, E.Ø., Brehm, L. and Krogsgaard-Larsen, P. (1989) ‘Excitatory amino acid agonists and partial agonists’, Drug Des. Del. 5: 57-71.
14. Christensen, I.T., Ebert, B., Madsen, U., Nielsen, B., Brehm, L. and Krogsgaard-Larsen, P. (1992) ‘Excitatory amino acid receptor ligands. Synthesis and biological activity of 3-isoxazolol amino acids structurally related to homoibotenic acid’, J. Med. Chem. 35: 3512-3519.
15. Clarke, V.R.J., Ballyk, B.A., Hoo, K.H., Mandelzys, A., Pellizzari, A., Bath, C.P., Thomas, J., Sharpe, E.F., Davies, C.H., Ornstein, P.L., Schoepp, D.D., Kamboj, R.K., Collingridge, G.L., Lodge, D. and Bleakman, D. (1997) ‘A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission’, Nature 389: 599-603.
16. Collingridge, G.L. and Lester, R.A.S. (1989) ‘Excitatory amino acid receptors in the vertebrate central nervous system’, Pharmacol. Rev. 40: 145-195.
17. Desai, M.A., Burnett, J.P., Ornstein, P.L. and Schoepp, D.D. (1995) ‘Cyclothiazide acts at a site on the α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor complex that does not recognize competitive or noncompetitive AMPA receptor antagonists’, J. Pharmacol. Exp. Ther. 272: 38-43.
18. Donevan, S.D. and Rogawski, M.A. (1993) ‘GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses’, Neuron 10: 51-59.
19. Donevan, S.D. and Rogawski, M.A. (1998) ‘Allosteric regulation of α-amino-3-hydroxy-5-methyl-4-isoxazole-propionate receptors by thiocyanate and cyclothiazide at a common modulatory site distinct from that of 2,3-benzodiazepines’, Neuroscience 87: 615-629.
20. Donevan, S.D., Beg, A., Gunther, J.M. and Twyman, R.E. (1998) ‘The methylglutamate, SYM 2081, is a potent and highly selective agonist at kainate receptors’, J. Pharmacol. Exp. Ther. 285: 539-545.
21. Ebert, B., Madsen, U., Lund, T.M., Holm, T. and Krogsgaard-Larsen, P. (1992) ‘Molecular pharmacology of cortical and spinal AMPA receptors’, Mol. Neuropharmacol. 2: 47-49.
22. Ebert, B., Lenz, S., Brehm, L., Bregnedal, P., Hansen, J.J., Frederiksen, K., Bøgesø, K.P. and Krogsgaard-Larsen, P. (1994a) ‘Resolution, absolute stereochemistry, and pharmacology of the (S)-(+)- and (R)-(-)-isomers of the apparent partial AMPA receptor agonist (R, S)-2-amino-3-(3-hydroxy-5-phenylisoxazol-4-yl)propionic acid [(R, S)-APPA]’, J. Med. Chem. 37: 878-884.
23. Ebert, B., Madsen, U., Lund, T.M., Lenz, S.M. and Krogsgaard-Larsen, P. (1994b) ‘Molecular pharmacology of the AMPA agonist (S)-2-amino-3-(3-hydroxy-5-phenyl-4-isoxazolyl)propionic acid [(S)-APPA] and the AMPA antagonist, (R)-APPA’, Neurochem. Int. 24: 507-515.
24. Egebjerg, J., Bettler, B., Hermans, B.I. and Heinemann, S. (1991) ‘Cloning of a cDNA for a glutamate receptor subunit activated by kainate but not AMPA’, Nature 351: 745-748.
25. Eugene, D., Moss, S.J. and Smart, T.G. (1996) ‘Thiocyanate ions inhibit AMPA-activated currents in recombinant non-NMDA receptors expressed in Xenopus laevis oocytes: the role of the GluR2 subunit’, Eur. J. Neurosci. 8: 1983-1993.
26. Evans, R.H., Jones, A.W. and Watkins, J.C. (1980) ‘Willardiine: a potent quisqualate-like excitant’, J. Physiol. (London) 308: 71P-72P.
27. Falch, E., Brehm, L., Mikkelsen, I., Johansen, T.N., Skjærbæk, N., Nielsen, B., Stensbøl, T.B., Ebert, B. and Krogsgaard-Larsen, P. (1998) ‘Heteroaryl analogues of AMPA. 2. Synthesis, absolute stereochemistry, photochemistry, and structure-activity relationships’, J. Med. Chem. 41: 2513-2523.
28. 3H]Aniracetam binds to specific recognition sites in brain membranes’, J. Neurochem. 65: 912-918.
29. Fletcher, E.J. and Lodge, D. (1996) ‘New developments in the molecular pharmacology of α-amino-3-hydroxy-5-methyl-4-isoxazole propionate and kainate receptors’, Pharmacol. Ther. 70: 65-89.
30. Fletcher, E.J., Martin, D., Aram, J.A., Lodge, D. and Honoré, T. (1988) ‘Quinoxalinediones selectively block quisqualate and kainate receptors and synaptic events in rat neocortex and hippocampus and frog spinal cord in vitro’, Br. J. Pharmacol. 95: 585-597.
31. Foster, A.C. and Fagg, G.E. (1984) ‘Acidic amino acid binding sites in mammalian neuronal membranes: their characteristics and relationship to synaptic receptors’, Brain Res. Rev. 7: 103-164.
32. Gu, Z.-Q., Hesson, D.P., Pelletier, J.C., Maccecchini, M.-L., Zhou, L.M. and Skolnick, P. (1995) ‘Synthesis, resolution, and biological evaluation of the four stereoisomers of 4-methylglutamic acid: selective probes of kainate receptors’, J. Med. Chem. 38: 2518-2520.
33. Hansen, J.J. and Krogsgaard-Larsen, P. (1980) ‘Isoxazole amino acids as glutamic acid agonists. Synthesis of some analogues and homologues of ibotenic acid’, J. Chem. Soc. Perkin Trans. I: 1826-1833.
34. Hansen, J.J., Lauridsen, J., Nielsen, E. and Krogsgaard-Larsen, P. (1983) ‘Enzymic resolution and binding to rat brain membranes of the glutamic acid agonist α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid’, J. Med. Chem. 26: 901-903.
35. Hansen, J.J., Nielsen, B., Krogsgaard-Larsen, P., Brehm, L., Nielsen, E.Ø. and Curtis, D.R. (1989) ‘Excitatory amino acid agonists. Enzymic resolution, X-ray structure and enantioselective activities of (R)- and (S)-bromohomoibotenic acid’, J. Med. Chem. 32: 2254-2260.
36. Hansen, J.J., Jørgensen, F.S., Lund, T.M., Nielsen, B., Reinhardt, A., Breum, I., Brehm, L. and Krogsgaard-Larsen, P. (1992) ‘AMPA receptor agonists: structural, conformational and stereochemical aspects’, in P. Krogsgaard-Larsen and J.J. Hansen (eds) Excitatory Amino Acid Receptors: Design of Agonists and Antagonists, Chichester: Ellis Horwood, pp. 216-245.
37. 3H]-5-fluorowillardiine in rat brain’, Br. J. Pharmacol. 116: 2033-2039.
38. Honoré, T. and Nielsen, M. (1985) ‘Complex structure of quisqualate-sensitive glutamate receptors in rat cortex’, Neurosci. Lett. 54: 27-32.
39. Honoré, T., Davies, S.N., Drejer, J., Fletcher, E.J., Jacobsen, P., Lodge, D. and Nielsen, F.E. (1988) ‘Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists’, Science 241: 701-703.
40. Huettner, J.E. (1990) ‘Glutamate receptor channels in rat DRG neurons: activation by kainate and quisqualate and blockade of desensitization by Con A’, Neuron 5: 255-266.
41. Isaacson, J.S. and Nicoll, R.A. (1991) ‘Aniracetam reduces glutamate receptor desensitization and slows the decay of fast excitatory synaptic currents in the hippocampus’, Proc. Natl. Acad. Sci. USA 88: 10,936-10,940.
42. Ishida, M. and Shinozaki, H. (1988) ‘Acromelic acid is a much more potent excitant than kainic acid or domoic acid in the isolated rat spinal cord’, Brain Res. 474: 386-389.
43. Iwama, T., Nagai, Y., Tamura, N., Harada, S. and Nagaoka, A. (1991) ‘A novel glutamate agonist, TAN-950 A, isolated from streptomycetes’, Eur. J. Pharmacol. 197: 187-192.
44. Jane, D.E., Hoo, K., Kamboj, R., Deverill, M., Bleakman, D. and Mandelzys, A. (1997) ‘Synthesis of willardiine and 6-azawillardiine analogs: pharmacological characterization on cloned homomeric human AMPA and kainate receptor subtypes’, J. Med. Chem. 40: 3645-3650.
45. 3H]kainate binding’, Eur. J. Pharmacol. Mol. Pharmacol. Sect. 246: 195-204.
46. Johansen, T.N, Ebert, B., Falch, E. and Krogsgaard-Larsen, P. (1997a) ‘AMPA receptor agonists: resolution, configurational assignment, and pharmacology or (+)-(S)- and (-)-(R)-2-amino-3-[3-hydroxy-5-(2-pyridyl)-isoxazol-4]-propionic acid (2-Py-AMPA)', Chirality 9: 274-280.
47. Johansen, T.N., Frydenvang, K., Ebert, B., Madsen, U. and Krogsgaard-Larsen, P. (1997b) ‘Excitatory amino acid receptor antagonists: resolution, absolute stereochemistry, and pharmacology of (S)- and (R)-2-amino-2-(5-tert-butyl-3-hydroxyisoxazol-4-yl)acetic acid (ATAA)', Chirality 9: 529-536.
48. Johansen, T.N., Ebert, B., Bräuner-Osborne, H., Didriksen, M., Christensen, I.T., Søby, K.K., Madsen, U., Krogsgaard-Larsen, P. and Brehm, L. (1998) ‘Excitatory amino acid receptor ligands: resolution, absolute stereochemistry, and enantiopharmacology of 2-amino-3-(4-butyl-3-hydroxyisoxazolyl-5-yl)propionic acid’, J. Med. Chem. 41: 930-939.
49. Johansen, T.N., Stensbøl, T., Neilsen, B., Vogensen, S.B., Frydenvang, K., Sløk, F., Bräuner-Osborne, H., Madsen, U. and Krogsgaard-Larsen (2001) ‘Resolution, configurational assignment and enantiopharmacology at glutamate receptors of 2-amino-3-(3-carboxy-5-methyl-4-isoxazolyl)propionic acid (ACPA) and Demethyl-ACPA’, Chirality (in press).
50. Jones, K.A., Wilding, T.J., Huettner, J.E. and Costa, A.-M. (1997) ‘Desensitization of kainate receptors by kainate, glutamate and diastereomers of 4-methylglutamate’, Neuropharmacology 36: 853-863.
51. Krogsgaard-Larsen, P., Honoré, T., Hansen, J.J., Curtis, D.R. and Lodge, D. (1980) ‘New class of glutamate agonist structurally related to ibotenic acid’, Nature 284: 64-66.
52. Krogsgaard-Larsen, P., Brehm, L., Johansen, J.S., Vinzents, P., Lauridsen, J. and Curtis, D.R. (1985) ‘Synthesis and structure-activity studies on excitatory amino acids structurally related to ibotenic acid’, J. Med. Chem. 28: 673-679.
53. Krogsgaard-Larsen, P., Ferkany, J.W., Nielsen, E.Ø., Madsen, U., Ebert, B., Johansen, J.S., Diemer, N.H., Bruhn, T., Beattie, D.T. and Curtis, D.R. (1991) ‘Novel class of amino acid antagonists at non-N-methyl-D-aspartic acid excitatory amino acid receptors. Synthesis, in vitro and in vivo pharmacology, and neuroprotection’, J. Med. Chem. 34: 123-130.
54. Lauridsen, J., Honoré, T. and Krogsgaard-Larsen, P. (1985) ‘Ibotenic acid analogues. Synthesis, molecular flexibility, and in vitro activity of agonists and antagonists at central glutamic acid receptors’, J. Med. Chem. 28: 668-672.
55. Madsen, U., Schaumburg, K., Brehm, L., Curtis, D.R. and Krogsgaard-Larsen, P. (1986) ‘Ibotenic acid analogues. Synthesis and biological testing of two bicyclic 3-isoxazolol amino acids’, Acta Chem. Scand. B40: 92-97.
56. Madsen, U., Brehm, L., Schaumburg, K., Jørgensen, F.S. and Krogsgaard-Larsen, P. (1990) ‘Relationship between structure, conformational flexibility, and biological activity of agonists and antagonists at the N-methyl-D-aspartic acid subtype of excitatory amino acid receptors’, J. Med. Chem. 33: 374-380.
57. Madsen, U., Ebert, B., Krogsgaard-Larsen, P. and Wong, E.H.F. (1992) ‘Synthesis and pharmacology of (RS)-2-amino-3-(3-hydroxy-5-flouromethyl-4-isoxazolyl)propionic acid, a potent AMPA receptor agonist’, Eur. J. Med. Chem. 27: 479-484.
58. Madsen, U. and Wong, E.H.F. (1992) ‘Heterocyclic excitatory amino acids. Synthesis and biological activity of novel analogues of AMPA’, J. Med. Chem. 35: 107-111.
59. Madsen, U., Ebert, B., Hansen, J.J. and Krogsgaard-Larsen, P. (1993a) ‘The non-depolarizing D-form of bromohomoibotenic acid enhances depolarizations evoked by the L-form or quisqualate’, Eur. J. Pharmacol. 230: 383-386.
60. Madsen, U., Frølund, B., Lund, T.M., Ebert, B. and Krogsgaard-Larsen, P. (1993b) ‘Design, synthesis and pharmacology of model compounds for indirect elucidation of the topography of AMPA receptor sites’, Eur. J. Med. Chem. 28: 791-800.
61. Madsen, U., Bang-Andersen, B., Brehm, L., Christensen, I.T., Ebert, B., Kristoffersen, I.T.S., Lang, Y. and Krogsgaard-Larsen, P. (1996) ‘Synthesis and pharmacology of highly selective carboxy and phosphono isoxazole amino acid AMPA receptor antagonists’, J. Med. Chem. 39: 1682-1691.
62. Madsen, U., Sløk, F.A., Stensbøl, T.B., Bräuner-Osborne, H., Lützhøft, H.-C.H., Poulsen, M., Eriksen, L. and Krogsgaard-Larsen, P. (2000) ‘Ionotropic excitatory amino acid receptor ligands. Synthesis and pharmacology of a new amino acid AMPA antagonist’, Eur. J. Med. Chem. 35: 69-76.
63. McLennan, H. and Lodge, D. (1979) ‘The antagonism of amino acid-induced excitation of spinal neurons in the cat’, Brain Res. 169: 83-90.
64. Monaghan, D.T., Bridges, R.J. and Cotman, C.W. (1989) ‘The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system’, Ann. Rev. Pharmacol. Toxicol. 29: 365-402.
65. Møller, E.H., Egebjerg, J., Brehm, L., Stensbøl, T.B., Johansen, T.N., Madsen, U. and Krogsgaard-Larsen, P. (1999) ‘Resolution, absolute stereochemistry, and enantiopharmacology of the GluR1-4 and GluR5 antagonist 2-amino-3-[5-tert-butyl-3-(phosphonomethoxy)-4-isoxazolyl]propionic acid’, Chirality 11: 752-759.
66. Nielsen, B., Fisker, H., Ebert, B., Madsen, U., Curtis, D.R., Krogsgaard-Larsen, P. and Hansen, J.J. (1993) ‘Enzymatic resolution of AMPA by use of a-chymotrypsin’, Bioorg. Med. Chem. Lett. 3: 107-114.
67. Ohmori, J., Sakamoto, S., Kubota, H., Shimizu-Sasamata, M., Okada, M., Kawasaki, S., Hidaka, K., Togami, J., Furuya, T. and Murase, K. (1994) '6-(1H-Imidazol-1-yl)-7-nitro-2,3-(1H,4H)-quinoxalinedione hydrochloride (YM90K) and related compounds: structure-activity relationships for the AMPA-type non-NMDA receptor’, J. Med. Chem. 37: 467-475.
68. O’Neill, M.J., Bond, A., Ornstein, P.L., Ward, M.A., Hicks, C.A., Hoo, K., Bleakman, D. and Lodge, D. (1998) ‘Decahydroisoquinolines: novel competitive AMPA/kainate antagonists with neuroprotective effects in global cerebral ischaemia’, Neuropharmacology 37: 1211-1222.
69. Ornstein, P.L., Arnold, M.B., Augenstein, N.K., Lodge, D., Leander, D.J. and Schoepp, D.D. (1993) '(3SR,4aRS,6RS,8aRS)-6-[2-(1H-Tetrazol-5-yl)ethyl)decahydroisoquinoline-3-carboxylic acid: a structurally novel, systematically active, competitive AMPA receptor antagonist’, J. Med. Chem. 36: 2046-2048.
70. Paternain, A.V., Morales, M. and Lerma, J. (1995) ‘Selective antagonism of AMPA receptors unmasks kainate receptor-mediated responses in hippocampal neurons’, Neuron 14: 185-189.
71. Patneau, D.K. and Mayer, M.L. (1990) ‘Structure-activity relationships for amino acid transmitter candidates acting at N-methyl-D-aspartate and quisqualate receptors’, J. Neurosci. 10: 2385-2399.
72. Patneau, D.K., Mayer, M.L., Jane, D.E. and Watkins, J.C. (1992) ‘Activation and desensitization of AMPA/kainate receptors by novel derivatives of willardiine’, J. Neurosci. 12: 595-606.
73. Patneau, D.K., Vyklicky, L.J. and Mayer, M.L. (1993) ‘Hippocampal neurons exhibit cyclothiazidesensitive rapidly desensitizing responses to kainate’, J. Neurosci. 13: 595-606.
74. Sheardown, M.J., Nielsen, E.Ø., Hansen, A.J., Jacobsen, P. and Honoré, T. (1990) '2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline. A neuroprotectant for cerebral ischemia’, Science 247: 571-574.
75. Shinozaki, H. (1988) ‘Pharmacology of the glutamate receptor’, Prog. Neurobiol. 30: 399-435.
76. Shinozaki, H. (1992) ‘Kainic acid receptor agonists’, in P. Krogsgaard-Larsen and J.J. Hansen (eds) Excitatory Amino Acid Receptors: Design of Agonists and Antagonists, Chichester: Ellis Horwood, pp. 261-291.
77. Skjærbæk, N., Ebert, B., Falch, E., Brehm, L. and Krogsgaard-Larsen, P. (1995) ‘Excitatory amino acids. Synthesis of (RS)-2-amino-3-(5-cyclopropyl-3-hydroxyisoxazol-4-yl)propionic acid, a new potent and specific AMPA receptor agonist’, J. Chem. Soc. Perkin Trans. I: 221-225.
78. Sladeczek, F., Pin, J.P., Récasens, M., Bockaert, J. and Wiess, S. (1985) ‘Glutamate stimulates inositol phosphate formation in striatal neurons’, Nature 317: 717-719.
79. Sløk, F.A., Ebert, B., Lang, Y., Krogsgaard-Larsen, P., Lenz, S.M. and Madsen, U. (1997) ‘Excitatory amino acid receptor agonists. Synthesis and pharmacology of analogues of 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid (AMPA)', Eur. J. Med. Chem. 32: 329-338.
80. Stensbøl, T.B., Borre, L., Johansen, T.N., Egebjerg, J., Madsen, U., Ebert, B. and Krogsgaard-Larsen, P. (1999a) ‘Resolution, absolute stereochemistry and molecular pharmacology of the enantiomers of ATPA’, Eur. J. Pharmacol. 380: 153-162.
81. 3H]2-amino-3-(3-carboxy-5-methyl-4-isoxazolyl)propionic acid’, Eur. J. Pharmacol. 373: 251-262.
82. Swanson, G.T., Green, T. and Heinemann, S.F. (1998) ‘Kainate receptors exhibit differential sensitivities to (S)-5-iodowillardiine’, Mol. Pharmacol. 53: 942-949.
83. Tarnawa, I., Farkas, S., Berzsenyi, P., Pataki, A. and Andrási, F. (1989) ‘Electrophysiological studies with a 2,3-benzodiazepine muscle relaxant: GYKI52466', Eur. J. Pharmacol. 167: 193-199.
84. Turski, L., Jacobsen, P., Honoré, T. and Stephens, D.N. (1992) ‘Relief of experimental spasticity and anxiolytic/anticonvulsant actions of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(F)quinoxaline’, J. Pharmacol. Exp. Ther. 260: 742-747.
85. Turski, L., Huth, A., Sheardown, M., McDonald, F., Neuhaus, R., Schneider, H.H., Dirnagl, U., Wiegand, F., Jacobsen, P. and Ottow, E. (1998) ‘ZK200775: A phosphonate quinoxazolinedione AMPA antagonist for neuroprotection in stroke and trauma’, Proc. Natl. Acad. Sci. USA 95: 10,960-10,965.
86. Verdoorn, T.A., Johansen, T.H., Drejer, J. and Nielsen, E.Ø. (1994) ‘Selective block of recombinant GluR6 receptors by NS-102, a novel non-NMDA receptor antagonist’, Eur. J. Pharmacol. 269: 43-49.
87. Wahl, P., Nielsen, B., Krogsgaard-Larsen, P., Hansen, J.J., Schousboe, A. and Miledi, R. (1992) ‘Stereoselective effects of AMOA on non-NMDA receptors expressed in Xenopus oocytes’, J. Neurosci. Res. 33: 392-397.
88. Wahl, P., Madsen, U., Banke, T., Krogsgaard-Larsen, P. and Schousboe, A. (1996) ‘Different characteristics of AMPA receptor agonists acting at AMPA receptors expressed in Xenopus oocytes’, Eur. J. Pharmacol. 308: 211-218.
89. Wahl, P., Anker, C., Traynelis, S.F., Egebjerg, J., Rasmussen, J.S., Krogsgaard-Larsen, P. and Madsen, U. (1998) ‘Antagonist properties of a phosphono isoxazole amino acid at glutamate R1-4 (R, S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid receptor subtypes’, Mol. Pharmacol. 53: 590-596.
90. Wätjen, F., Nielsen, E.Ø., Drejer, J. and Jensen, L.H. (1993) ‘Isatin oximes - a novel series of bioavailable non-NMDA antagonists’, Bioorg. Med. Chem. Lett. 3: 105-106.
91. Wätjen, F., Bigge, C.F., Jensen, L.H., Boxer, P.A., Lescosky, L.J., Nielsen, E.Ø., Malone, T.C., Campbell, G.W., Coughenour, L.L., Rock, D.M., Drejer, J. and Marcoux, F.W. (1994) ‘NS 257 (1,2,3,6,7,8-hexahydro-3-(hydroxyimino)-N, N,7-trimethyl-2-oxobenzo[2,1-b:3,4-c’]dipyrrole-5-sulfonamide) is a potent, systemically active AMPA receptor antagonist’, Bioorg. Med. Chem. Lett. 4: 371-376.
92. Watkins, J.C. and Evans, R.H. (1981) ‘Excitatory amino acid transmitters’, Annu. Rev. Pharmacol. Toxicol. 21: 165-204.
93. Watkins, J.C., Krogsgaard-Larsen, P. and Honoré, T. (1990) ‘Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists’, Trends Pharmacol. Sci. 11: 25-33.
94. Wilding, T.J. and Huettner, J.E. (1995) ‘Differential antagonism of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-preferring and kainate-preferring receptors by 2,3-benzodiazepines’, Mol. Pharmacol. 47: 582-587.
95. Young, A.B. and Fagg, G.E. (1990) ‘Excitatory amino acid receptors in the brain: membrane binding and receptor autoradiographic approaches’, Trends Pharmacol. Sci. 11: 126-133.
96. Zorumski, C.F., Yamada, K.A., Price, M.T. and Olney, J.W. (1993) ‘A benzodiazepine recognition site associated with the non-NMDA glutamate receptor’, Neuron 10: 61-67.